Teladoc Health (NYSE:TDOC) PT Lowered to $15.00 at TD Cowen

Teladoc Health (NYSE:TDOC) had its price target decreased by TD Cowen from $16.00 to $15.00 in a report released on Friday, Benzinga reports. TD Cowen currently has a hold rating on the health services provider’s stock.

A number of other equities analysts also recently commented on the company. Piper Sandler reduced their price objective on Teladoc Health from $30.00 to $25.00 and set an overweight rating on the stock in a research report on Wednesday, February 21st. Cantor Fitzgerald assumed coverage on Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 price objective on the stock. Royal Bank of Canada reduced their price objective on Teladoc Health from $30.00 to $25.00 and set an outperform rating on the stock in a research report on Wednesday, February 21st. Stifel Nicolaus reduced their target price on Teladoc Health from $21.00 to $16.00 and set a hold rating on the stock in a research report on Friday. Finally, Leerink Partnrs restated a market perform rating on shares of Teladoc Health in a research report on Monday, February 26th. Eleven analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of $19.67.

Teladoc Health Price Performance

Shares of TDOC opened at $13.01 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. Teladoc Health has a 12 month low of $12.65 and a 12 month high of $30.41. The stock’s 50 day moving average is $15.01 and its two-hundred day moving average is $17.77.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The business’s revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.37) earnings per share. As a group, sell-side analysts expect that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Andrew Turitz sold 6,190 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the sale, the executive vice president now owns 39,429 shares of the company’s stock, valued at $572,509.08. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the sale, the insider now directly owns 57,223 shares in the company, valued at approximately $1,097,537.14. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock worth $2,038,251 over the last ninety days. Company insiders own 1.63% of the company’s stock.

Institutional Trading of Teladoc Health

Large investors have recently added to or reduced their stakes in the company. Lecap Asset Management Ltd. acquired a new position in shares of Teladoc Health in the fourth quarter worth $1,530,000. Sowell Financial Services LLC increased its stake in shares of Teladoc Health by 40.8% in the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after acquiring an additional 5,475 shares during the last quarter. Deutsche Bank AG increased its stake in shares of Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock worth $5,598,000 after acquiring an additional 33,287 shares during the last quarter. Sherbrooke Park Advisers LLC acquired a new position in shares of Teladoc Health in the third quarter worth $680,000. Finally, QRG Capital Management Inc. acquired a new position in shares of Teladoc Health in the third quarter worth $392,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.